Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
World Journal of Surgery
Erschienen in: World Journal of Surgery 8/2013

01.08.2013

Extended Lymphadenectomy in Esophageal Cancer is Debatable

verfasst von: Fernando A. M. Herbella, Rafael M. Laurino Neto, Marco E. Allaix, Marco G. Patti

Erschienen in: World Journal of Surgery | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Surgery is an essential part of the treatment of patients with esophageal carcinoma. However, there is no consensus on whether the surgical technique can be improved to promote better survival outcome. Specifically, the real value of the addition of a radical lymphadenectomy to the esophageal resection is still elusive and controversial. This paper focuses on the debate of esophagectomy and lymphadenectomy for the treatment of esophageal cancer.
Literatur
1.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM (2010) GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer. Available at http://​globocan.​iarc.​fr (accessed on November 2012)
2.
Schuchert MJ, Luketich JD, Landreneau RJ (2010) Management of esophageal cancer. Curr Probl Surg 47(11):845–946PubMedCrossRef
3.
Kelsen D (1984) Chemotherapy of esophageal cancer. Semin Oncol 11(2):159–168PubMed
4.
Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67:381–390PubMedCrossRef
5.
Worni M, Martin J, Gloor B, Pietrobon R, D’Amico TA, Akushevich I, Berry MF (2012) Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg 215(5):643–651PubMedCrossRef
6.
Williams VA, Watson TJ, Herbella FA, Gellersen O, Raymond D, Jones C, Peters JH (2007) Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 11(12):1589–1597PubMedCrossRef
7.
Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103PubMedCrossRef
8.
Ra J, Paulson EC, Kucharczuk J, Armstrong K, Wirtalla C, Rapaport-Kelz R, Kaiser LR, Spitz FR (2008) Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol 15(6):1577–1584PubMedCrossRef
9.
Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG (2009) Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference: a follow-up analysis of another decade. Ann Surg 250(3):472–483PubMed
10.
Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248(4):549–556PubMed
11.
Preston SR, Markar SR, Baker CR, Soon Y, Singh S, Low DE (2013) Impact of a multidisciplinary standardized clinical pathway on perioperative outcomes in patients with oesophageal cancer. Br J Surg 100(1):105–112. doi:10.​1002/​bjs.​8974 PubMedCrossRef
12.
Low DE, Kunz S, Schembre D, Otero H, Malpass T, Hsi A, Song G, Hinke R, Kozarek RA (2007) Esophagectomy–it’s not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. J Gastrointest Surg 11(11):1395–1402; discussion 1402
13.
Herbella FA, Patti MG (2010) Minimally invasive esophagectomy. World J Gastroenterol 16(30):3811–3815PubMedCrossRef
14.
Vallbohmer D, Oh DS, Peters JH (2012) The role of lymphadenectomy in the surgical treatment of esophageal and gastric cancer. Curr Probl Surg 49(8):471–515PubMedCrossRef
15.
Halsted WS (1898) I. A clinical and histological study of certain adenocarcinomata of the breast: and a brief consideration of the supraclavicular operation and of the results of operations for cancer of the breast from 1889 to 1898 at the Johns Hopkins hospital. Ann Surg 28(5):557–576PubMed
16.
Patti MG, Gantert W, Way LW (1997) Surgery of the esophagus. Anatomy and physiology. Surg Clin North Am 77(5):959–970PubMedCrossRef
17.
Logan A (1963) The surgical treatment of carcinoma of the esophagus and cardia. J Thorac Cardiovasc Surg 46:150–161PubMed
18.
Skinner DB (1983) En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 85(1):59–71PubMed
19.
Prenzel KL, Bollschweiler E, Schröder W, Mönig SP, Drebber U, Vallboehmer D, Hölscher AH (2010) Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg 90(5):1662–1667PubMedCrossRef
20.
Yajin S, Murakami G, Takeuchi H, Hasegawa T, Kitano H (2009) The normal configuration and interindividual differences in intramural lymphatic vessels of the esophagus. J Thorac Cardiovasc Surg 137(6):1406–1414PubMedCrossRef
21.
Grotenhuis BA, van Heijl M, Zehetner J, Moons J, Wijnhoven BP, van Berge Henegouwen MI, Tilanus HW, DeMeester TR, Lerut T, van Lanschot JJ (2010) Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy? Ann Surg 252(5):823–830PubMedCrossRef
22.
Liebermann-Meffert D (2001) Anatomical basis for the approach and extent of surgical treatment of esophageal cancer. Dis Esophagus 14(2):81–84PubMedCrossRef
23.
Herbella FA, Del Grande JC, Colleoni R, Japanese Society for Disease of the Esophagus (2003) Anatomical analysis of the mediastinal lymph nodes of normal Brazilian subjects according to the classification of the Japanese Society for Diseases of the Esophagus. Surg Today 33(4):249–253PubMedCrossRef
24.
Genereux GP, Howie JL (1984) Normal mediastinal lymph node size and number: CT and anatomic study. AJR Am J Roentgenol 142(6):1095–1100PubMedCrossRef
25.
Quint LE, Glazer GM, Orringer MB, Francis IR, Bookstein FL (1986) Mediastinal lymph node detection and sizing at CT and autopsy. AJR Am J Roentgenol 147(3):469–472PubMedCrossRef
26.
Kiyono K, Sone S, Sakai F, Imai Y, Watanabe T, Izuno I, Oguchi M, Kawai T, Shigematsu H, Watanabe M (1988) The number and size of normal mediastinal lymph nodes: a postmortem study. AJR Am J Roentgenol 150(4):771–776PubMedCrossRef
27.
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232PubMedCrossRef
28.
Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H et al (1994) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 219:310–316PubMedCrossRef
29.
Sharma S, Fujita H, Yamana H, Kakegawa T (1994) Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagus. Surg Today 24:410–414PubMedCrossRef
30.
Shen Y, Zhang Y, Tan L, Feng M, Wang H, Khan MA, Liang M, Wang Q (2012) Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center. J Gastrointest Surg 16(4):715–721PubMedCrossRef
31.
Dubecz A, Molena D, Peters JH (2008) Modern surgery for esophageal cancer. Gastroenterol Clin North Am 37(4):965–987, xi
32.
Villaflor VM, Allaix ME, Minsky B, Herbella FA, Patti MG (2012) Multidisciplinary approach for patients with esophageal cancer. World J Gastroenterol 18(46):6737–6746PubMedCrossRef
33.
Daly JM, Fray WA, Little AG et al (2000) Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 190:562–573PubMedCrossRef
34.
Natsugoe S, Nakashima S, Nakajo A, Matsumoto M, Okumura H, Tokuda K, Miyazono F, Kijima F, Aridome K, Ishigami S, Takao S, Aikou T (2003) Bone marrow micrometastasis detected by RT-PCR in esophageal squamous cell carcinoma. Oncol Rep 10(6):1879–1883PubMed
35.
Nakamura T, Matsunami K, Hayashi K, Ota M, Ide H, Takasaki K (2004) Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation. Oncol Rep 11(5):999–1003PubMed
36.
Vashist YK, Effenberger KE, Vettorazzi E, Riethdorf S, Yekebas EF, Izbicki JR, Pantel K (2012) Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer. Ann Surg 255(6):1105–1112PubMedCrossRef
37.
Yekebas EF, Schurr PG, Kaifi JT, Link BC, Kutup A, Mann O, Wolfram L, Izbicki JR (2006) Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases. J Surg Oncol 93(7):541–549PubMedCrossRef
38.
Daiko H, Nishimura M (2012) A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc 26(3):673–680PubMedCrossRef
39.
Prenzel KL, Hölscher AH, Drebber U, Agavonova M, Gutschow CA, Bollschweiler E (2012) Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol 38(4):314–318PubMedCrossRef
40.
Barbour AP, Jones M, Brown I, Gotley DC, Martin I, Thomas J, Clouston A, Smithers BM (2010) Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 17(9):2494–2502PubMedCrossRef
41.
Altorki NK, Girardi L, Skinner DB (1997) En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg 114(6):948–955; discussion 955–956
42.
Tabira Y, Okuma T, Kondo K, Kitamura N (1999) Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 117(2):239–245PubMedCrossRef
43.
Alderson D, Courtney SP, Kennedy RH (1994) Radical transhiatal oesophagectomy under direct vision. Br J Surg 81(3):404–407PubMedCrossRef
44.
Bumm R, Feussner H, Bartels H, Stein H, Dittler HJ, Höfler H, Siewert JR (1997) Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg 21(8):822–831. doi:10.​1007/​PL00024609 PubMed
45.
Herbella FA, Del Grande JC, Colleoni R (2002) Efficacy of mediastinal lymphadenectomy in transhiatal esophagectomy with and without diaphragm opening: a cadaveric study. Dis Esophagus 15(2):160–162PubMedCrossRef
46.
Hu Y, Hu C, Zhang H, Ping Y, Chen LQ (2010) How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol 17(3):784–790PubMedCrossRef
47.
Groth SS, Virnig BA, Whitson BA, DeFor TE, Li ZZ, Tuttle TM, Maddaus MA (2010) Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg 139(3):612–620PubMedCrossRef
48.
Veeramachaneni NK, Zoole JB, Decker PA, Putnam JB Jr, Meyers BF; American College of Surgeons Oncology Group Z0060 Trial (2008) Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Ann Thorac Surg 86(2):418–421; discussion 421. doi:10.​1016/​j.​athoracsur.​2008.​04.​043
49.
50.
Hagen JA, Peters JH, DeMeester TR (1993) Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 106(5):850–858; discussion 858–859
51.
Rizzetto C, DeMeester SR, Hagen JA et al (2008) En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg 135:1228–1236PubMedCrossRef
52.
53.
Imamura Y, Hayashi N, Sato N, Kinoshita K, Kurashige J, Saito S, Hirashima K, Karashima R, Hiyoshi Y, Nagai Y, Watanabe M, Baba H (2010) Extensive lymphatic spread of cancer cells in patients with thoracic esophageal squamous cell carcinoma: detection of CEA-mRNA in the three-field lymph nodes. J Surg Oncol 102(5):509–515. doi:10.​1002/​jso.​21621 PubMedCrossRef
54.
55.
Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240(6):962–972; discussion 972–974
56.
Altorki N, Kent M, Ferrara C, Port J (2012) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236(2):177–183CrossRef
57.
58.
59.
Patti MG, Corvera CU, Glasgow RE, Way LW (1998) A hospital’s annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 2(2):186–192PubMedCrossRef
60.
Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, Coupland VH, Wouters MW, Lemmens VE, van de Velde CJ, van der Geest LG, Larsson HJ, Cats A, Verheij M (2013) Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg 100(1):83–94. doi:10.​1002/​bjs.​8966 PubMedCrossRef
61.
Markar SR, Karthikesalingam A, Thrumurthy S, Low DE (2012) Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000–2011. J Gastrointest Surg 16(5):1055–1063. doi:10.​1007/​s11605-011-1731-3 PubMedCrossRef
62.
63.
64.
65.
Block MI (2006) Transthoracic vs. transhiatal esophagectomy: stage migration muddies the water. J Surg Oncol 93(7):519–520PubMedCrossRef
66.
Portale G, Hagen JA, Peters JH, Chan LS, DeMeester SR, Gandamihardja TA, DeMeester TR (2006) Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202(4):588–596; discussion 596–598
67.
Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EH (2010) Optimum lymphadenectomy for esophageal cancer. Ann Surg 251(1):46–50. doi:10.​1097/​SLA.​0b013e3181b2f6ee​ PubMedCrossRef
68.
69.
Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP (2008) Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 112(6):1239–1246. doi:10.​1002/​cncr.​23309 PubMedCrossRef
70.
Rusch VW, Rice TW, Crowley J, Blackstone EH, Rami-Porta R, Goldstraw P (2010) The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J Thorac Cardiovasc Surg 139:819–821PubMedCrossRef
71.
Hsu PK, Wu YC, Chou TY, Huang CS, Hsu WH (2010) Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor–node–metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg 89:1024–1031PubMedCrossRef
72.
Gaur P, Hofstetter WL, Bekele BN et al (2010) Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg 89:1797–1803, 1804.e1-3; discussion 1803–1804. doi:10.​1016/​j.​athoracsur.​2010.​02.​048
73.
Talsma K, van Hagen P, Grotenhuis BA, Steyerberg EW, Tilanus HW, van Lanschot JJB, Wijnhoven BPL (2012) Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol 19(7):2142–2148PubMedCrossRef
74.
75.
Merkow RP, Bilimoria KY, McCarter MD, Phillips JD, Decamp MM, Sherman KL, Ko CY, Bentrem DJ (2012) Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation. Arch Surg 147(11):1009–1016PubMedCrossRef
76.
Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, Fujii T, Yamasaki K, Higaki K, Noake T et al (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 222(5):654–662PubMedCrossRef
77.
Baba M, Aikou T, Natsugoe S, Kusano C, Shimada M, Kimura S, Fukumoto T (1997) Lymph node and perinodal tissue tumor involvement in patients with esophagectomy and three-field lymphadenectomy for carcinoma of the esophagus. J Surg Oncol 64(1):12–16PubMedCrossRef
78.
Sugiyama M, Morita M, Yoshida R, Ando K, Egashira A, Takefumi O, Saeki H, Oki E, Kakeji Y, Sakaguchi Y, Maehara Y (2012) Patterns and time of recurrence after complete resection of esophageal cancer. Surg Today 42(8):752–758. doi:10.​1007/​s00595-012-0133-9 PubMedCrossRef
79.
Li CL, Zhang FL, Wang YD, Han C, Sun GG, Liu Q, Cheng YJ, Jing SW, Yang CR (2013) Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett 5(1):355–359PubMed
80.
Chou SH, Chuang HY, Huang MF, Lee CH, Yau HM (2009) A prospective comparison of transthoracic and transhiatal resection for esophageal carcinoma in Asians. Hepatogastroenterology 56(91–92):707–710PubMed
81.
Chu KM, Law SY, Fok M, Wong J (1997) A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 174(3):320–324PubMedCrossRef
82.
Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B (1993) Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 80(3):367–370PubMedCrossRef
83.
Rindani R, Martin CJ, Cox MR (1999) Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust N Z J Surg 69(3):187–194PubMedCrossRef
84.
Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ (2001) Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 72(1):306–313PubMedCrossRef
85.
Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246(6):992–1000; discussion 1000–1001
86.
Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, Kakeji Y, Yamanaka T, Maehara Y (2008) Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 143(4):499–508. doi:10.​1016/​j.​surg.​2007.​12.​007 PubMedCrossRef
87.
Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL (2007) Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246(3):363–372; discussion 372–374
88.
Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175:47–51PubMedCrossRef
89.
Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239(4):483–490PubMedCrossRef
90.
91.
92.
Vigneswaran WT, Trastek VF, Pairolero PC, Deschamps C, Daly RC, Allen MS (1993) Transhiatal esophagectomy for carcinoma of the esophagus. Ann Thorac Surg 56(4):838–844; discussion 844–846
93.
Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N (2005) Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 189(1):98–109PubMedCrossRef
Metadaten
Titel
Extended Lymphadenectomy in Esophageal Cancer is Debatable
verfasst von
Fernando A. M. Herbella
Rafael M. Laurino Neto
Marco E. Allaix
Marco G. Patti
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 8/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2018-5

Weitere Artikel der Ausgabe 8/2013

World Journal of Surgery 8/2013 Zur Ausgabe

OriginalPaper

Systematic Review and Meta-analysis of Enhanced Recovery After Pancreatic Surgery with Particular Emphasis on Pancreaticoduodenectomies

Letter

Local Pain-reducing Methods after Hemorrhoidectomy

OriginalPaper

Nationally Representative Household Survey of Surgery and Mortality in Sierra Leone

OriginalPaper

Pretraining Experience and Structure of Surgical Training at a Sub-Saharan African University

OriginalPaper

Therapeutic Approach to Patients With a Lower-Pitched Voice After Thyroidectomy

OriginalPaper

Lipocalin-2 is Associated With a Good Prognosis and Reversing Epithelial-to-Mesenchymal Transition in Pancreatic Cancer

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.
Bildnachweise